A multicenter, randomized, comparative study to determine the appropriate dose of lansoprazole for use in the diagnostic test for gastroesophageal reflux disease

Gut and Liver

Volumn 5, Issue 3, 2011, Pages 302-307

  Lee, Si Hyung ^a   Jang, Byung Ik ^a   Jeon, Seong Woo ^b   Kwon, Joong Goo ^c   Kim, Eun Young ^c   Cho, Kwang Bum ^d   Park, Chang Geun ^e   Yang, Chang Heon ^f  

^a Yeungnam University College of Medicine   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Keimyung University   (South Korea)

^e Department of Internal Medicine   (South Korea)

^f Dongguk University College of Medicine   (South Korea)

Author keywords

Diagnosis; Dose; Gastroesophageal reflux disease; Lansoprazole

Indexed keywords

LANSOPRAZOLE;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIARRHEA; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG INDUCED HEADACHE; DRUG RESPONSE; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; MULTICENTER STUDY; NON EROSIVE REFLUX DISEASE; PATIENT COMPLIANCE; PROTON PUMP INHIBITOR TEST; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; SCORING SYSTEM; SOUTH KOREA; TREATMENT DURATION;

EID: 80052429233     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.3.302     Document Type: Article

References (16)

1. Vakil N., Van Zanten S.V., Kahrilas P., Dent J., Jones R.; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920.
2. Richter J.E. The many manifestations of gastroesophageal reflux disease: Presentation, evaluation, and treatment. Gastroenterol Clin North Am 2007;36:577-599, viii-ix. (Pubitemid 47577500)
3. Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol 1997;92:1997-2000. (Pubitemid 27476237)
4. Fass R., Ofman J.J., Gralnek I.M., et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999;159:2161-2168. (Pubitemid 29483155)
5. Schindlbeck N.E., Klauser A.G., Voderholzer W.A., Müller-Lissner S.A. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995;155:1808-1812.
6. Johnsson F., Weywadt L., Solhaug J.H., Hernqvist H., Bengtsson L. One-week omeprazole treatment in the diagnosis of gastrooesophageal reflux disease. Scand J Gastroenterol 1998;33:15-20. (Pubitemid 28114063)
7. Johnsson F., Hatlebakk J.G., Klintenberg A.C., et al. One-week esomeprazole treatment: An effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 2003;38:354-359. (Pubitemid 36606304)
8. Juul-Hansen P., Rydning A., Jacobsen C.D., Hansen T. High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol 2001;36:806-810. (Pubitemid 32656554)
9. DeVault K.R., Castell D.O.; American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005;100:190-200. (Pubitemid 41623288)
10. Dent J., El-Serag H.B., Wallander M.A., Johansson S. Epidemiology of gastro-oesophageal reflux disease: A systematic review. Gut 2005;54:710-717. (Pubitemid 40559260)
11. Wong W.M., Lai K.C., Lam K.F., et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: A population-based study. Aliment Pharmacol Ther 2003;18:595-604. (Pubitemid 37186609)
12. Kim N., Lee S.W., Cho S.I., et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: A nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther 2008;27:173-185. (Pubitemid 350256608)
13. Cho Y.S., Choi M.G., Jeong J.J., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 2005;100:747-753.
14. Fass R., Ofman J.J., Sampliner R.E., Camargo L., Wendel C., Fennerty M.B. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000;14:389-396. (Pubitemid 30199214)
15. Bruley des Varannes S., Levy P., Lartigue S., Dellatolas F., Lemaire M., Galmiche J.P. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994;8:309-314. (Pubitemid 24205530)
16. Des Varannes S.B., Sacher-Huvelin S., Vavasseur F., et al. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. World J Gastroenterol 2006;12:2569-2573.